Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / June / The Retinas Lost Lipid Signal
Omics Omics News and Research Clinical

The Retina’s Lost Lipid Signal

High-resolution metabolomics identifies erucamide depletion in retinal degeneration and links restoration to neurovascular rescue

06/30/2026 3 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Clinical Report: The Retina’s Lost Lipid Signal

Overview

A Scripps Research-led team has identified erucamide as a lipid signal associated with retinal degeneration. The study found that erucamide levels decrease as photoreceptors deteriorate.

Background

Retinal degeneration is a significant cause of vision loss, and understanding the underlying mechanisms is crucial. The identification of lipid signals like erucamide may provide insights into the neurovascular response during retinal injury.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Erucamide levels are significantly depleted in RCS rats and rd10 mice models of retinal degeneration.
  • Restoring erucamide improves retinal layer thickness and scotopic ERG responses in treated mice.
  • Erucamide is taken up by CD11b+ retinal myeloid cells, indicating its role in the retinal response to injury.
  • TMEM19 has been identified as a candidate erucamide-binding protein, influencing the signaling response.
  • Mechanistic studies suggest that erucamide engages the surrounding retinal environment rather than targeting photoreceptors directly.

Clinical Implications

The findings indicate a focus on the retinal environment and signaling pathways in retinal degenerative diseases.

Conclusion

This study presents erucamide as a lipid signal in retinal health and disease, warranting further investigation.

Related Resources & Content

  1. Retinal Physician, 2026 -- Recognizing MacTel Masquerades
  2. Retinal Physician, 2025 -- ApoM Pathway May Offer New Target for Early AMD Intervention
  3. Retinal Physician, 2022 -- Complications From Macular Peeling
  4. AAO 2025: Age-Related Macular Degeneration Guidelines - Medthority
  5. Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study | Ophthalmic Surgery, Lasers and Imaging Retina
  6. Retinal Physician — FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina.
  7. AAO 2025: Age-Related Macular Degeneration Guidelines - Medthority
  8. Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study | Ophthalmic Surgery, Lasers and Imaging Retina
  9. Retinal Neurovascular Coupling: From Mechanisms to a Diagnostic Window into Brain Disorders - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.